Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03975491 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Exercise And Colorectal Cancer Treatment Trial

Study acronym: EXACT
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Study completion date changed from estimate of Jan 1, 2026 to Feb 28, 2025
    • Eligibility criteria expanded, about 18 words
    • Publications: details revised at 3 of 3 entries
  2. Results first posted: Sep 22, 2025v16 Show 5 more changesShow less
    • Primary endpoints revised (2)
    • Trial status: Completed to Active, Not Recruiting
    • Study completion date: Jan 1, 2025 to Jan 1, 2026
    • Secondary endpoints revised (3)
    • Publications: 2 to 3
  3. Primary completion date: Jun 1, 2024 to May 1, 2023
    • Trial status: Active, Not Recruiting to Completed
    • Study completion date changed from estimate of Jul 31, 2025 to Jan 1, 2025
    • Start date: Aug 16, 2019 to Aug 1, 2019
    v15
  4. Study completion date: Jul 31, 2024 to Jul 31, 2025v14
  5. Primary completion date: May 16, 2023 to Jun 1, 2024
    • Study completion date: Apr 30, 2025 to Jul 31, 2024
    v13
Show 11 earlier versionsHide 11 earlier versions
  1. Study completion date: Apr 30, 2024 to Apr 30, 2025v12
  2. Eligibility criteria shortened, about 21 words
    • Secondary endpoints: 4 to 3
    • Study description expanded, about 2 words
    v11
  3. Primary completion date changed from estimate of Apr 30, 2023 to May 16, 2023v10
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v9
  5. Primary completion date: Jul 30, 2022 to Apr 30, 2023
    • Study completion date: Jul 31, 2023 to Apr 30, 2024
    v8
  6. Primary completion date: Jul 30, 2021 to Jul 30, 2022
    • Study completion date: Jul 31, 2022 to Jul 31, 2023
    v7
  7. Site contact updatedv6
  8. Trial status: Suspended to Recruitingv5 Show 4 more changesShow less
    • Study description revised
    • Site details revised
    • Study title revised
    • Eligibility criteria shortened, about 2 words
  9. Trial status: Recruiting to Suspended Sponsor's reason: Temporarily suspended due to COVID-19. The study is planned to re-open. Suspension does not relate to withdrawal of IRB approval.
    • Site details revised
    v4
  10. Secondary endpoints: 3 to 4v3
  11. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 1, 2019 to Aug 16, 2019
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.
Trial Details
NCT Number NCT03975491
Lead Sponsor Pennington Biomedical Research Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Colon Cancer, Rectal Cancer
Related terms Colonic Neoplasms, Rectal Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov